Press release
SMi Group announce 6th annual Admet conference, 6th & 7th July 2011
SMi Group are pleased to announce their 6th annual conference on Admet - Translating Research into Clinical Outcomes. Taking place on the 6th & 7th July 2011 in London, this event will address a wide range of in vivo, in silico and in vitro ADMET case studies in a showcase of examples from an internationally renowned line up of speakers with intimate knowledge of the latest industry developments.Key topics include:
• Metabonomics
• Optimisation and prediction
• Toxicity and genotoxicity
• Blood brain barrier and bioavailability
• In silico, in vitro and in vivo correlations
• PK/PD modeling
• Proteomics
This conference programme will be delivered by a high level speaker panel including:
• Mathieu Vinken, Pharm.D. Department of Toxicology, Vrije Universiteit Brussels
• Willem Schoonen Senior Research Scientist Toxicology & Drug Disposition MSD
• Mike Piper Senior Business Development Manager CXR Biosciences
• Alan Wilson, Vice President, Drug Metabolism, Pharmacokinetics, Toxicology and Pathology, Lexicon Pharmaceuticals
• Alexander Alex, Computational Chemistry, Pfizer
• Frederick Tam, Senior Clinical Lecturer/Hon. Consultant Nephrologist, Imperial College London
Helga Gerets, Senior Scientist, In Vitro Toxicology UCB Pharma
• Vibeke Sunesen, Pharmacokineticist, Preclinical Development, LEO Pharma
• Dieter Deforce, Professor, Laboratory of Pharmaceutical Biotechnology University of Gent
• Richard Weaver Associate Principal Scientist AstraZeneca
• aileta Prabhu, Senior Scientist/Group Leader, PKPDS, Development Sciences, Genentech
• Dolo Diaz, Investigative Safety Assessment, Genentech
• Balazs Sarkadi, Membrane Research Group, Hungarian Academy of Sciences.
• Gergely Szakacs, Senior Research Fellow at the Institute of Enzymology, Hungarian Academy of Sciences
• Dieter Deforce, Professor, Laboratory of Pharmaceutical Biotechnology University of Gent
• Pablo Morentin Gutierrez, Associate Principal Scientist, DMPK-IM, AstraZeneca
• John Comer, Technical Director, Sirius Analytical
• Andrew Brown, Senior Scientific Investigator, GlaxoSmithKline
• David Buckley, Principal Scientist, XenoTech
• Janice Yau Yi Lau Senior Group Leader Drug Metabolism Abbott
For more information and to book your place visit www.smi-online.co.uk/admet-event15.asp
The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefited from SMi's highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk
SMi Group
Unit 122, Great Guildford Street
London
SE1 0HS
Rachel Cowdrey
rcowdrey@smi-online.co.uk
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release SMi Group announce 6th annual Admet conference, 6th & 7th July 2011 here
News-ID: 167638 • Views: …
More Releases from SMi Group
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference
The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation.
Industry leaders will uncover the…
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK.
With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading…
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022.
With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and…
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week.
With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman.
The…
More Releases for Pharm
Fenbendazole Market Size, Share and Forecast By Key Players-Jin Dun Pharm, Shand …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Fenbendazole market is anticipated to grow at a compound annual growth rate (CAGR) of 16.05% between 2024 and 2031. The market is expected to grow to USD 68 Billion by 2024. The valuation is expected to reach USD 192.77 Billion by 2031.
The fenbendazole market is experiencing notable growth due to increasing awareness of parasitic infections in both…
Revolutionizing Revenue: Dexlansoprazole Sustained Release Capsule Market Trends …
Worldwide Market Reports announces the publication of its most recently generated research report titled, "Dexlansoprazole Sustained Release Capsule Market - Forecast to 2030", which offers a holistic view of the Dexlansoprazole Sustained Release Capsule market through systematic segmentation that covers every aspect of the target market. Dexlansoprazole Sustained Release Capsule with 100+ market data Tables, Pie Chat, Graphs, and Figures spread through Pages and easy-to-understand detailed analysis. The information is…
Paromomycin Sulfate Market 2030 by Top 10+ Players Pfizer,, Changrui Pharm,, ERF …
Paromomycin Sulfate is an antibiotic used to treat infections caused by certain parasites. It is commonly used to treat visceral leishmaniasis, a serious parasitic disease that affects the internal organs. The market for Paromomycin Sulfate is relatively small compared to other antibiotics, as it is primarily used to treat a specific type of parasitic infection. However, the market for Paromomycin Sulfate is expected to grow as the incidence of visceral…
Fosfomycin Market to Witness Huge Growth by 2026 | Northeast Pharm, Ercros, Shin …
The Latest Released Fosfomycin market study has evaluated the future growth potential of Global Fosfomycin market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities…
Clopidol Market updates, demand analysis, and expected growth forecast 2021-2027 …
Global “Clopidol” Market Size, Status, and Forecast 2021-2027. In-depth research accumulated to offer Latest insights about acute features of the global Clopidol market. This report provides a detailed overview of key factors in the Clopidol Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development. The effect of the COVID-19 outbreak at the enterprise turned into completely assessed. Fully chance evaluation and enterprise recommendations…
Paromomycin Market updates, demand analysis, and expected growth forecast 2021-2 …
The new study on the Global “Paromomycin Market” 2021-2027 analyzes the crucial capabilities, key infrastructures, major organizations, evaluates measures to attain potential success in the Paromomycin industry. Because of the in-depth overview of the Global Paromomycin market, the recent papers allow investors, traders, and manufacturers to plan some innovative techniques, and meanwhile, align them with operational and commercial enterprise models. Additionally, the Paromomycin market report offers crucial facets at the…
